About Twin anemia-polycythemia sequence

What is Twin anemia-polycythemia sequence?

Twin anemia-polycythemia sequence (TAPS) is a rare condition that affects identical twins. It occurs when one twin has an abnormally low number of red blood cells (anemia) and the other twin has an abnormally high number of red blood cells (polycythemia). This can lead to a number of complications, including an increased risk of intrauterine growth restriction, preterm delivery, and fetal death. Treatment typically involves the use of blood transfusions to correct the imbalance between the twins.

What are the symptoms of Twin anemia-polycythemia sequence?

The symptoms of Twin Anemia-Polycythemia Sequence (TAPS) vary depending on the severity of the condition, but may include:

-Low birth weight
-Anemia
-Jaundice
-Enlarged spleen
-Enlarged liver
-Heart defects
-Respiratory distress
-Growth retardation
-Neurological problems
-Cerebral palsy
-Developmental delays
-Feeding difficulties
-Kidney problems
-Hemorrhage
-Hydrops fetalis (accumulation of fluid in the fetus)
-Increased risk of stillbirth

What are the causes of Twin anemia-polycythemia sequence?

The exact cause of Twin Anemia-Polycythemia Sequence (TAPS) is unknown. However, it is believed to be caused by an imbalance in the placental circulation between the twins, resulting in one twin receiving more blood than the other. This can lead to one twin having anemia (low red blood cell count) and the other having polycythemia (high red blood cell count). Other possible causes include genetic factors, maternal vascular disease, and placental abnormalities.

What are the treatments for Twin anemia-polycythemia sequence?

The primary treatment for Twin Anemia-Polycythemia Sequence (TAPS) is laser photocoagulation of the placental vascular anastomoses. This procedure is used to reduce the amount of blood flow between the twins, which helps to reduce the risk of severe anemia in the donor twin. Other treatments may include intrauterine transfusions, exchange transfusions, and the use of medications such as hydroxyurea or erythropoietin. In some cases, the affected twin may need to be delivered early to prevent further complications.

What are the risk factors for Twin anemia-polycythemia sequence?

1. Advanced maternal age
2. Male gender
3. Monochorionic placentation
4. Discordant fetal growth
5. Discordant amniotic fluid volume
6. Discordant umbilical artery Doppler velocimetry
7. Discordant fetal hemoglobin levels
8. Discordant fetal red blood cell count
9. Discordant fetal platelet count
10. Discordant fetal white blood cell count
11. Discordant fetal liver size
12. Discordant fetal kidney size
13. Discordant fetal adrenal gland size
14. Discordant fetal thymus size
15. Discordant fetal thyroid size
16. Discordant fetal heart size
17. Discordant fetal lung size
18. Discordant fetal abdominal circumference
19. Discordant fetal head circumference
20. Discordant fetal abdominal

Is there a cure/medications for Twin anemia-polycythemia sequence?

Yes, there are treatments available for Twin anemia-polycythemia sequence. Treatment options include blood transfusions, medications to reduce the production of red blood cells, and medications to reduce the risk of clotting. In some cases, surgery may be necessary to separate the twins and reduce the risk of complications.